Special offer for anti-VEGF therapy for public hospital patients


Gleneagles supports a subsidy programme for patients who are following up designated ophthalmological illnesses* at public hospitals and required anti-VEGF therapy. Those patients can enjoy a special price at HK$7,650** (including doctor’s fee, medication and procedure charge) for anti-VEGF therapy at Gleneagles by referrals.

Interested patients can contact Hong Kong Health Care Alliance, which will refer eligible patients to Gleneagles. For further details, please refer to: https://bit.ly/2Vuzt0s (For enquiries/appointments, please contact Hong Kong Health Care Alliance at +852 3482 1976.)


The offer is valid until 31 December 2020 on a first-come, first-served basis.

* Designated ophthalmological illnesses include: wet age-related macular degeneration, diabetic macular edema, retinal vein occlusion and choroidal neovascularization


** T&C apply.

Enquiries/Appointments (Hong Kong Health Care Alliance):
+852 3482 1976

For other promotions, please visit here.